| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.571 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 28.571 | 394.667 | 3.139 | 0 | 0 | 0 | 0 | 0 | 0 | 183 |
| Total Expenses - EUR | 29.094 | 398.407 | 579 | 51 | 50 | 62 | 0 | 0 | 72 | 218 |
| Gross Profit/Loss - EUR | -523 | -3.741 | 2.559 | -51 | -50 | -62 | 0 | 0 | -72 | -35 |
| Net Profit/Loss - EUR | -523 | -3.741 | 2.520 | -51 | -50 | -62 | 0 | 0 | -72 | -35 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Avena Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 403.815 | 251.514 | 243.428 | 238.961 | 234.333 | 229.890 | 224.792 | 225.490 | 224.806 | 0 |
| Current Assets | 881.643 | 32.874 | 45.124 | 31.744 | 31.129 | 42.615 | 41.670 | 41.799 | 29.865 | 34.606 |
| Inventories | 355.516 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 509.679 | 16.594 | 29.100 | 16.014 | 15.704 | 27.482 | 26.873 | 26.956 | 15.067 | 15.574 |
| Cash | 16.447 | 16.279 | 16.024 | 15.730 | 15.425 | 15.133 | 14.797 | 14.843 | 14.798 | 19.032 |
| Shareholders Funds | 42.218 | 38.047 | -355.435 | -348.963 | -342.255 | -335.829 | -328.382 | -329.400 | -328.474 | -326.673 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.243.240 | 246.341 | 643.987 | 619.668 | 607.717 | 608.334 | 594.844 | 596.689 | 583.144 | 361.279 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Avena Medica Srl